The Traderszone Network

Published in TZ Latest News 13 August, 2014 by The TZ Newswire Staff

Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal

European regulators are going to want to see survival data for Kyprolis.

read more